Compare · AMEH vs ASTH
AMEH vs ASTH
Side-by-side comparison of Apollo Medical Holdings Inc. (AMEH) and Astrana Health Inc. (ASTH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMEH and ASTH operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- AMEH is the larger of the two at $2.62B, about 1.4x ASTH ($1.90B).
- ASTH has hit the wire 8 times in the past 4 weeks while AMEH has been quiet.
- AMEH has more recent analyst coverage (9 ratings vs 6 for ASTH).
- Company
- Apollo Medical Holdings Inc.
- Astrana Health Inc.
- Price
- $40.83-2.20%
- $34.42+0.66%
- Market cap
- $2.62B
- $1.90B
- 1M return
- -
- +40.43%
- 1Y return
- -
- +9.62%
- Industry
- Professional Services
- Professional Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 8
- Recent ratings
- 9
- 6
Apollo Medical Holdings Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Latest AMEH
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Apollo Medical Hlgs Q4 2023 GAAP EPS $0.26 Beats $0.15 Estimate, Sales $353.04M Beat $340.61M Estimate
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Apollo Medical Hlgs's Earnings Outlook
- Jefferies Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $50
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Apollo shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $44 to $55.
- B of A Securities Upgrades Apollo Medical Hlgs to Buy, Raises Price Target to $55
- Apollo Medical upgraded by BofA Securities with a new price target
- Apollo Medical Holdings Announced That It Will Formally Change Its Name From Apollo Medical Holdings, Inc. To Astrana Health, Inc. And Will Begin Trading Under The Ticker Symbol "ASTH", Both Effective February 26, 2024
Latest ASTH
- Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call
- SEC Form DEFA14A filed by Astrana Health Inc.
- SEC Form DEF 14A filed by Astrana Health Inc.
- SEC Form 4 filed by Basho Chandan
- Astrana Health, Inc. to Participate in Upcoming Investor Conferences
- SEC Form 4 filed by Lam Thomas S.
- SEC Form 4 filed by Sim Kenneth T.
- SEC Form 4 filed by Sim Brandon
- SEC Form 4 filed by Kumar Dinesh M.
- SEC Form 4 filed by Basho Chandan